Skip to main content

Dopaminergic System in the Aged Brain: Evidence for a Selective Loss of D-1 But Not D-2 Receptors

  • Conference paper

Part of the book series: NATO ASI Series ((ASIH,volume 9))

Abstract

Although aging of the brain is often associated with disease, it has been demonstrated that more than 70% of old people lives until death without evident signs of cerebral pathology. The so-called well preserved aged show a slight impairment of many psychological and neurological functions. Over the past ten years, a few significant concepts rose from studies on neurotransmitters and receptors in the aged brain: the plasticity of neurons and synapses, a neuronal hierarchy, a differential vulnerability and the so-called threshold phenomena (Bergener et al., 1985; Walker et al., 1983). Studies on plasticity of neurons and synaptogenesis are one of the most encouraging field for understanding normal and pathological aging and for generating drugs which can help to avert and to treat diseases. An increased dendritic synaptogenesis has been reported in neocortex following complex environment exposure both in adult and old rats (Greenough W., 1984). Although this event may diminish in senescent animals, the data suggest that the capacity for experience-dependent synaptogenesis is maintained through a significant proportion of the life-span. This is of particular interest for learning and memory. In fact, such a synaptic efficiency may well be a nuerophysiological mechanism for storage of information in the central nervous system.

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   84.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Bacopulos N. G. (1981) Acute changes in the state of dopamine receptors; in vitro monitoring with 3H-dopamine. Life Sci 29: 2407–2414

    Article  Google Scholar 

  • Bergener M., Ermini M., Stahelin H. B. (eds.) (1985) Thresholds in Aging, Academic Press, London

    Google Scholar 

  • Bernheimer H., Birkmayer W., Hornykiewicz O., Jellinger K., Scitelberger F. (1973) Brain dopamine and the syndrome of Parkinson and Huntington. J Neurol Sci 20: 415–455.

    Article  PubMed  CAS  Google Scholar 

  • Creese I. and Snyder S. H. (1978) 3H-Spiroperidol labels serotonin receptors in rat cerebral cortex and hippocampus. Eur J Pharmacol 49: 201–202

    Google Scholar 

  • De Camilli P., Macconi D., Spada A. (1979) Dopamine inhibits adenylate cyclase in human prolactin-secreting pituitary adenomas. Nature 278: 252–254

    Article  PubMed  Google Scholar 

  • Giorgi O., De Montis M. G. Calderini G., Toffano G., Biggio G. (1986) Postnatal development of D-l dopamine receptors in rat striatum. Soc Neurosci Abstr 12: 987

    Google Scholar 

  • Govoni S., Loddo P., Spano P. F., Trabucchi M. (1977) Dopamine receptor sensitivity in brain and retina of rats during aging. Brain Res 138: 565–571.

    Article  PubMed  CAS  Google Scholar 

  • Greenough W. (1984) Structural correlates of information storage in the mammalian brain: a review and hypothesis. Trends Neurosci 7: 229–233.

    Article  Google Scholar 

  • Hahn R. A., Wardell J. R. Jr, Saran H. M., Ridely P. T. (1982) Characterization of the peripheral and central effects of SKF 82526 a novel dopamine receptor agonist. J Pharm Exp Ther 223: 305–313

    CAS  Google Scholar 

  • Hornykiewicz O. (1979) Brain dopamine in Parkinson’s disease and other neurological disturbances. In: Neurobiology of Dopamine ( Horn S. A., Korf J., Westerink B. H. C. eds.) pp 633–654, Academic Press, London

    Google Scholar 

  • Iorio L. C., Barnett A., Leitz F. H., Houser V. P., Korduba C. A. (1983) SCH 23390, a potential benzazepine antipsychotic with unique interaction on dopaminergic system. J Pharm Exp Ther 226: 462–468

    CAS  Google Scholar 

  • Kebabian J. W. and Calne D. B. (1979) Multiple receptors for dopamine. Nature 277: 252–254.

    Article  Google Scholar 

  • Lee T., Seeman P., Rajput A., Farely I. J., Hornykiewicz O. (1978) Receptor basis for dopaminergic supersensitivity in Parkinson’s disease. Nature 273: 59–61

    Article  PubMed  CAS  Google Scholar 

  • Leysen J. E., Gommeren W., Laduron P. (1978) Spiperone: a ligand of choice for neuroleptic receptors 1. Kinetics and characteristics of in vitro binding. Biochem Pharmacol 27: 307–316

    Google Scholar 

  • Memo M., Lucchi L., Spano P. F., Trabucchi M. (1980) Aging process affects a single class of dopamine receptor. Brain Res 202: 488–492

    Article  PubMed  CAS  Google Scholar 

  • Morgan D. G., Marcusson J. O., Winblad B., Finch C. E: (1984) Reciprocal changes in D-l and D-2 dopamine binding sites in human caudate nucleus and putamen during normal aging. Soc Neurosci Abstr 10: 445.

    Google Scholar 

  • O’Boyle K. H. and Waddington J. L. (1984) Loss of striatal dopamine receptors with aging is selective for D-2 but not D-l sites: association with increased non-specific binding of the D-l ligand 3H-piflutixol. Eur J Pharmacol 105: 171–174.

    Article  PubMed  Google Scholar 

  • Onali P. L., Olianas M. C., Gessa G. L. (1985) Characterization of dopamine receptors mediating inhibition of adenylate cyclase activity in rat striatum. Mol Pharmacol 28: 138–145.

    PubMed  CAS  Google Scholar 

  • Palacios J. M., Niehroff D. L., Kuhar M. J. (1981) 3H-spiperone binding sites in brain: autoradiographic localization of multiple receptors. Brain Res 213, 277–289

    Google Scholar 

  • Peroutka S. J., U’Prichard D. C., Greenberg D. A., Snyder S. H. (1977) Neuroleptic drug interactions with norepinephrine alpha receptor binding sites in rat brain. Neuropharmacology 16: 549–556

    Article  PubMed  CAS  Google Scholar 

  • Pradhan S. N. (1980) Central Neurotransmitters and aging. Life Sci 26: 1643–1656

    Article  PubMed  CAS  Google Scholar 

  • Puri S. K. and Volicer L. (1976) Effect of aging on cyclic AMP levels and adenylate cyclase and phosphodiesterase activities in the rat corpus striatum. Mech Aging and Develop 6: 53–58

    Article  CAS  Google Scholar 

  • Roth G. S. and Joseph J. A. (1985) Modulation of changes in dopaminergic receptors and responsiveness during aging. In: Thresholds In Aging ( Bergener M., Ermini M., Stahelin H. B. eds.) Academic Press, London

    Google Scholar 

  • Schmidt M. J. and Thornberry J. F. (1978) Cyclic AMP and cyclic GMP accumulation in vitro in brain regions of young, old, and aged rats. Brain Res 139: 169–177.

    Article  PubMed  CAS  Google Scholar 

  • Seeman P. (1980) Brain dopamine receptors. Pharmacol Rev 32: 229–313

    PubMed  CAS  Google Scholar 

  • Severson J. A. and Finch C. E. (1980) Reduced dopaminergic binding during aging in the rodent striatum. Brain Res 192: 147–162

    Article  PubMed  CAS  Google Scholar 

  • Severson J. A., Marcusson J., Winbald B., Finch C. E. (1982) Age-correlated loss of dopaminergic binding sites in human basal ganglia. J Neurochem 39: 1623–1631.

    Article  PubMed  CAS  Google Scholar 

  • Spano P. F., Govoni S., Trabucchi M. (1978) Studies on the pharmacological properties of dopamine receptors in various areas of the central nervous system. Adv Biochem Psychopharmacol 19: 155–165.

    PubMed  CAS  Google Scholar 

  • Stoof J. C. and Kebabian J. W. (1981) Opposing roles for D-l and D-2 dopamine receptors in efflux of cyclic AMP from rat neostriatum. Nature 294: 366–368.

    Article  PubMed  CAS  Google Scholar 

  • Thai L. J., Horowitz S. G., Dvorkin B., Makman M. H. (1980) Evidence for loss of brain 3H-ADTN binding sites in rabbit brain with aging. Brain Res 192: 185–194.

    Article  Google Scholar 

  • Walker R. F. and Cooper R. L. (eds.) (1983) Experimental and Clinical Interventions in Aging, Dekker, New York.

    Google Scholar 

  • Wong D. F., Wagner H. N., Dannals R. F., Links J. M., Frost J. J., Ravert H. T., Wilson A. A., Rosenbaum A. E., Gjedde A., Douglass K. H., Petronis J. D., Folstein M. F., Toung J. K. T., Burns H. D., Khuar M. J. (1984) Effects of age on dopamine and serotonine receptors measured by positron emission tomography in the living human brain. Science 226: 1393–1396.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1987 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

Missale, C., Memo, M., Spano, P.F. (1987). Dopaminergic System in the Aged Brain: Evidence for a Selective Loss of D-1 But Not D-2 Receptors. In: Govoni, S., Battaini, F. (eds) Modification of Cell to Cell Signals During Normal and Pathological Aging. NATO ASI Series, vol 9. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-72729-0_12

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-72729-0_12

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-72731-3

  • Online ISBN: 978-3-642-72729-0

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics